Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (54 quarters reported)
$3.18B in Q2 2013 → $687M now. Hover for any quarter.
As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Cava Group Inc | 51.3% | Unchanged | 6,507,990 | $352M |
| Lexicon Pharmaceuticals Inc | 48.0% | Unchanged | 175,156,062 | $329M |
| Iqm Quantum Computers Oyj | 0.8% | New | 500,000 | $5.19M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2026 · filed November 12, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Iqm Quantum Computers Oyj | New | +500,000 | +$5.19M | 0.8% |
quarter ended June 30, 2026 · filed August 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cava Group Inc | Trimmed | −3,000,000 | −$235M | 54.9% |
| Lexicon Pharmaceuticals Inc | Added | +20,421,735 | +$49M | 45.1% |
quarter ended March 31, 2026 · filed May 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc | Added | +18,553,846 | +$28.9M | 23.9% |
quarter ended December 31, 2025 · filed February 12, 2026
No position changes this quarter.
quarter ended September 30, 2025 · filed November 12, 2025
No position changes this quarter.
quarter ended June 30, 2025 · filed August 13, 2025
No position changes this quarter.
quarter ended March 31, 2025 · filed May 14, 2025
No position changes this quarter.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cava Group Inc | Trimmed | −8,000,000 | −$902M | 91.4% |
Loading...